Medical costs incurred by organ damage caused by active disease, comorbidities and side effect of treatments in systemic lupus erythematosus patients: a Taiwan nationwide population-based study
Crossref DOI link: https://doi.org/10.1007/s00296-016-3551-y
Published Online: 2016-08-17
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chiu, Y. M.
Chuang, M. T.
Lang, H. C.
Funding for this research was provided by:
GlaxoSmithKline
License valid from 2016-08-17